Natural Product-based Synthetic Drug Molecules in Alzheimer's Disease : Therapeutic & Theranostic Agents

個数:

Natural Product-based Synthetic Drug Molecules in Alzheimer's Disease : Therapeutic & Theranostic Agents

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 447 p.
  • 言語 ENG
  • 商品コード 9789819960408

Full Description

This book illustrates the importance of natural products as the source for the development of novel drugs for the treatment of neurodegenerative disorders, including Alzheimer's disease. It also highlights the role of reactive oxygen species and altered metal homeostasis in the progression of Alzheimer's disease and examines the potential of antioxidants and anti-chelating agents in the clinical intervention of neurodegenerative diseases. The book also discusses the role of neuroinflammation in the pathogenesis of Alzheimer's disease. The chapters provide information about the drug targets, progress in the development of natural product-based therapeutics, biomarkers, fluorescent diagnostic tools, and theranostic for Alzheimer's disease. The book also provides information about the design and synthesis of natural product-based derivatives against the various targets of Alzheimer's disease including epigenetic targets and the metal dyshomeostasis hypothesis. Cutting across different disciplines, this book is a valuable source for neuroscientists, chemical biologists, pharmaceutical researchers, and synthetic biologists.

Contents

Section 1: Introduction of Alzheimer's Disease.- Chapter 1: Alzheimer's disease and drug targets.- Chapter 2: Oxidative stress and metals in Alzheimer's disease.- Chapter 3: Neuroinflammation in Alzheimer's disease.- Section 2:  Biomarkers and Diagnosis in Alzheimer's Disease.- Chapter 4: Biomarkers of Alzheimer's disease.- Chapter 5: Naturally inspired fluorescent organic molecules as diagnostic and theranostic tools in Alzheimer's disease.- Chapter 6: Nanostructure-based molecules as diagnostic and theranostic tools in AD.- Section 3:  Drug derivatives: A strategy for new multifunctional drug development for Alzheimer's Disease.- Chapter 7: Approved cholinesterase inhibitors-based derivatives: Synthesis and their biological evaluation.- Chapter 8: Memantine-based derivatives: Synthesis and their biological evaluation.- Section 4: Natural molecules inspired novel derivatives for Alzheimer's Disease.- Chapter 9: Huperzine-based derivatives: Design, synthesis, and anti-Alzheimer activity.- Chapter 10: Polyphenol: Development of polyphenol-inspired derivatives targeting pathological factors of AD.- Chapter 11: Flavonoid-based derivatives for modulating various targets of Alzheimer's disease.- Chapter 12: Vitamin-based derivatives for the management of Alzheimer's disease.- Section 5: Metal dyshomeostasis: A hypothesis for developing drugs for the treatment of Alzheimer's disease.- Chapter 13: Metal chelators as a potential therapeutic agent for Alzheimer's disease.- Chapter 14: Ferroptosis modulators: A potential therapeutic target in Alzheimer's disease.- Section 6. Natural products/Synthetic molecules as epigenetic modulators in Alzheimer's disease.- Chapter 15. Sirtuin modulator: Design, synthesis, and biological evaluation.- Chapter 16. Histone deacetylase Inhibitors: Design, synthesis, and biological evaluation.

最近チェックした商品